Epithelial-derived interleukin-23 promotes oral mucosal immunopathology
At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the...
Gespeichert in:
Veröffentlicht in: | Immunity (Cambridge, Mass.) Mass.), 2024-04, Vol.57 (4), p.859-875.e11 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 875.e11 |
---|---|
container_issue | 4 |
container_start_page | 859 |
container_title | Immunity (Cambridge, Mass.) |
container_volume | 57 |
creator | Kim, Tae Sung Ikeuchi, Tomoko Theofilou, Vasileios Ionas Williams, Drake Winslow Greenwell-Wild, Teresa June, Armond Adade, Emmanuel E. Li, Lu Abusleme, Loreto Dutzan, Nicolas Yuan, Yao Brenchley, Laurie Bouladoux, Nicolas Sakamachi, Yosuke Palmer, Robert J. Iglesias-Bartolome, Ramiro Trinchieri, Giorgio Garantziotis, Stavros Belkaid, Yasmine Valm, Alex M. Diaz, Patricia I. Holland, Steven M. Moutsopoulos, Niki M. |
description | At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the prevalent oral disease periodontitis. Epithelial IL-23 expression localized to areas proximal to the disease-associated microbiome and was evident in experimental models and patients with common and genetic forms of disease. Mechanistically, flagellated microbial species of the periodontitis microbiome triggered epithelial IL-23 induction in a TLR5 receptor-dependent manner. Therefore, unlike other Th17-driven diseases, non-hematopoietic-cell-derived IL-23 served as an initiator of pathogenic inflammation in periodontitis. Beyond periodontitis, analysis of publicly available datasets revealed the expression of epithelial IL-23 in settings of infection, malignancy, and autoimmunity, suggesting a broader role for epithelial-intrinsic IL-23 in human disease. Collectively, this work highlights an important role for the barrier epithelium in the induction of IL-23-mediated inflammation.
[Display omitted]
•Epithelial IL-23 is evident in patients with common and Mendelian forms of periodontitis•Non-hematopoietic-cell-derived IL-23 is a pathogenic driver in experimental periodontitis•Flagellated microbes induce epithelial IL-23 through canonical TLR5 signaling•Epithelial IL-23 is evident across human barrier tissues and increased in Th17 diseases
Epithelial cells at mucosal surfaces provide a structural barrier and an immune defense system, but dysregulated epithelial responses can contribute to disease. Kim et al. reveal that epithelial-derived IL-23 is a pathogenic trigger in the oral mucosal disease periodontitis. Moreover, their findings suggest a broader role for epithelial-derived IL-23 in human Th17-mediated inflammatory diseases across barrier tissues. |
doi_str_mv | 10.1016/j.immuni.2024.02.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2974003417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1074761324000967</els_id><sourcerecordid>2974003417</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-be231b96e09dc6cfc92cbac21907d9114c8e9f6ee5b4bdf15be40f5d389f07883</originalsourceid><addsrcrecordid>eNp9UMtOwzAQtBCIlsIfINQjl4T1Iw9fkBAqBakSFzhbib2hLkkc7KRS_56UFo5II80eZnZ2h5BrCjEFmt5tYts0Q2tjBkzEwEbACZlSkFkkaA6n-zkTUZZSPiEXIWwAqEgknJMJzxPK0zSZkuWis_0aa1vUkUFvt2jmtu3R1zh82jZifN5517gew9z5op43g3Zh5J9w1xX92tXuY3dJzqqiDnh15Bl5f1q8PT5Hq9fly-PDKtI8ZX1UIuO0lCmCNDrVlZZMl4VmVEJmJKVC5yirFDEpRWkqmpQooEoMz2UFWZ7zGbk97B2v-how9KqxQWNdFy26ISgmMwHABc1GqThItXcheKxU521T-J2ioPYVqo06VKj2FSpgI2C03RwThrJB82f67WwU3B8EOP65tehV0BZbjcZ61L0yzv6f8A2RSoWK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2974003417</pqid></control><display><type>article</type><title>Epithelial-derived interleukin-23 promotes oral mucosal immunopathology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kim, Tae Sung ; Ikeuchi, Tomoko ; Theofilou, Vasileios Ionas ; Williams, Drake Winslow ; Greenwell-Wild, Teresa ; June, Armond ; Adade, Emmanuel E. ; Li, Lu ; Abusleme, Loreto ; Dutzan, Nicolas ; Yuan, Yao ; Brenchley, Laurie ; Bouladoux, Nicolas ; Sakamachi, Yosuke ; Palmer, Robert J. ; Iglesias-Bartolome, Ramiro ; Trinchieri, Giorgio ; Garantziotis, Stavros ; Belkaid, Yasmine ; Valm, Alex M. ; Diaz, Patricia I. ; Holland, Steven M. ; Moutsopoulos, Niki M.</creator><creatorcontrib>Kim, Tae Sung ; Ikeuchi, Tomoko ; Theofilou, Vasileios Ionas ; Williams, Drake Winslow ; Greenwell-Wild, Teresa ; June, Armond ; Adade, Emmanuel E. ; Li, Lu ; Abusleme, Loreto ; Dutzan, Nicolas ; Yuan, Yao ; Brenchley, Laurie ; Bouladoux, Nicolas ; Sakamachi, Yosuke ; Palmer, Robert J. ; Iglesias-Bartolome, Ramiro ; Trinchieri, Giorgio ; Garantziotis, Stavros ; Belkaid, Yasmine ; Valm, Alex M. ; Diaz, Patricia I. ; Holland, Steven M. ; Moutsopoulos, Niki M. ; NIDCD/NIDCR Genomics and Computational Biology Core</creatorcontrib><description>At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the prevalent oral disease periodontitis. Epithelial IL-23 expression localized to areas proximal to the disease-associated microbiome and was evident in experimental models and patients with common and genetic forms of disease. Mechanistically, flagellated microbial species of the periodontitis microbiome triggered epithelial IL-23 induction in a TLR5 receptor-dependent manner. Therefore, unlike other Th17-driven diseases, non-hematopoietic-cell-derived IL-23 served as an initiator of pathogenic inflammation in periodontitis. Beyond periodontitis, analysis of publicly available datasets revealed the expression of epithelial IL-23 in settings of infection, malignancy, and autoimmunity, suggesting a broader role for epithelial-intrinsic IL-23 in human disease. Collectively, this work highlights an important role for the barrier epithelium in the induction of IL-23-mediated inflammation.
[Display omitted]
•Epithelial IL-23 is evident in patients with common and Mendelian forms of periodontitis•Non-hematopoietic-cell-derived IL-23 is a pathogenic driver in experimental periodontitis•Flagellated microbes induce epithelial IL-23 through canonical TLR5 signaling•Epithelial IL-23 is evident across human barrier tissues and increased in Th17 diseases
Epithelial cells at mucosal surfaces provide a structural barrier and an immune defense system, but dysregulated epithelial responses can contribute to disease. Kim et al. reveal that epithelial-derived IL-23 is a pathogenic trigger in the oral mucosal disease periodontitis. Moreover, their findings suggest a broader role for epithelial-derived IL-23 in human Th17-mediated inflammatory diseases across barrier tissues.</description><identifier>ISSN: 1074-7613</identifier><identifier>ISSN: 1097-4180</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2024.02.020</identifier><identifier>PMID: 38513665</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>barrier immunity ; epithelial ; Epithelial Cells ; epithelial-intrinsic ; flagellin ; Humans ; IL-23 ; Inflammation ; Interleukin-23 ; oral mucosa ; pathogenic Th17 ; Periodontitis ; Pseudomonas aeruginosa ; TLR5 ; Toll-Like Receptor 5 - metabolism</subject><ispartof>Immunity (Cambridge, Mass.), 2024-04, Vol.57 (4), p.859-875.e11</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-be231b96e09dc6cfc92cbac21907d9114c8e9f6ee5b4bdf15be40f5d389f07883</citedby><cites>FETCH-LOGICAL-c362t-be231b96e09dc6cfc92cbac21907d9114c8e9f6ee5b4bdf15be40f5d389f07883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1074761324000967$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38513665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Tae Sung</creatorcontrib><creatorcontrib>Ikeuchi, Tomoko</creatorcontrib><creatorcontrib>Theofilou, Vasileios Ionas</creatorcontrib><creatorcontrib>Williams, Drake Winslow</creatorcontrib><creatorcontrib>Greenwell-Wild, Teresa</creatorcontrib><creatorcontrib>June, Armond</creatorcontrib><creatorcontrib>Adade, Emmanuel E.</creatorcontrib><creatorcontrib>Li, Lu</creatorcontrib><creatorcontrib>Abusleme, Loreto</creatorcontrib><creatorcontrib>Dutzan, Nicolas</creatorcontrib><creatorcontrib>Yuan, Yao</creatorcontrib><creatorcontrib>Brenchley, Laurie</creatorcontrib><creatorcontrib>Bouladoux, Nicolas</creatorcontrib><creatorcontrib>Sakamachi, Yosuke</creatorcontrib><creatorcontrib>Palmer, Robert J.</creatorcontrib><creatorcontrib>Iglesias-Bartolome, Ramiro</creatorcontrib><creatorcontrib>Trinchieri, Giorgio</creatorcontrib><creatorcontrib>Garantziotis, Stavros</creatorcontrib><creatorcontrib>Belkaid, Yasmine</creatorcontrib><creatorcontrib>Valm, Alex M.</creatorcontrib><creatorcontrib>Diaz, Patricia I.</creatorcontrib><creatorcontrib>Holland, Steven M.</creatorcontrib><creatorcontrib>Moutsopoulos, Niki M.</creatorcontrib><creatorcontrib>NIDCD/NIDCR Genomics and Computational Biology Core</creatorcontrib><title>Epithelial-derived interleukin-23 promotes oral mucosal immunopathology</title><title>Immunity (Cambridge, Mass.)</title><addtitle>Immunity</addtitle><description>At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the prevalent oral disease periodontitis. Epithelial IL-23 expression localized to areas proximal to the disease-associated microbiome and was evident in experimental models and patients with common and genetic forms of disease. Mechanistically, flagellated microbial species of the periodontitis microbiome triggered epithelial IL-23 induction in a TLR5 receptor-dependent manner. Therefore, unlike other Th17-driven diseases, non-hematopoietic-cell-derived IL-23 served as an initiator of pathogenic inflammation in periodontitis. Beyond periodontitis, analysis of publicly available datasets revealed the expression of epithelial IL-23 in settings of infection, malignancy, and autoimmunity, suggesting a broader role for epithelial-intrinsic IL-23 in human disease. Collectively, this work highlights an important role for the barrier epithelium in the induction of IL-23-mediated inflammation.
[Display omitted]
•Epithelial IL-23 is evident in patients with common and Mendelian forms of periodontitis•Non-hematopoietic-cell-derived IL-23 is a pathogenic driver in experimental periodontitis•Flagellated microbes induce epithelial IL-23 through canonical TLR5 signaling•Epithelial IL-23 is evident across human barrier tissues and increased in Th17 diseases
Epithelial cells at mucosal surfaces provide a structural barrier and an immune defense system, but dysregulated epithelial responses can contribute to disease. Kim et al. reveal that epithelial-derived IL-23 is a pathogenic trigger in the oral mucosal disease periodontitis. Moreover, their findings suggest a broader role for epithelial-derived IL-23 in human Th17-mediated inflammatory diseases across barrier tissues.</description><subject>barrier immunity</subject><subject>epithelial</subject><subject>Epithelial Cells</subject><subject>epithelial-intrinsic</subject><subject>flagellin</subject><subject>Humans</subject><subject>IL-23</subject><subject>Inflammation</subject><subject>Interleukin-23</subject><subject>oral mucosa</subject><subject>pathogenic Th17</subject><subject>Periodontitis</subject><subject>Pseudomonas aeruginosa</subject><subject>TLR5</subject><subject>Toll-Like Receptor 5 - metabolism</subject><issn>1074-7613</issn><issn>1097-4180</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UMtOwzAQtBCIlsIfINQjl4T1Iw9fkBAqBakSFzhbib2hLkkc7KRS_56UFo5II80eZnZ2h5BrCjEFmt5tYts0Q2tjBkzEwEbACZlSkFkkaA6n-zkTUZZSPiEXIWwAqEgknJMJzxPK0zSZkuWis_0aa1vUkUFvt2jmtu3R1zh82jZifN5517gew9z5op43g3Zh5J9w1xX92tXuY3dJzqqiDnh15Bl5f1q8PT5Hq9fly-PDKtI8ZX1UIuO0lCmCNDrVlZZMl4VmVEJmJKVC5yirFDEpRWkqmpQooEoMz2UFWZ7zGbk97B2v-how9KqxQWNdFy26ISgmMwHABc1GqThItXcheKxU521T-J2ioPYVqo06VKj2FSpgI2C03RwThrJB82f67WwU3B8EOP65tehV0BZbjcZ61L0yzv6f8A2RSoWK</recordid><startdate>20240409</startdate><enddate>20240409</enddate><creator>Kim, Tae Sung</creator><creator>Ikeuchi, Tomoko</creator><creator>Theofilou, Vasileios Ionas</creator><creator>Williams, Drake Winslow</creator><creator>Greenwell-Wild, Teresa</creator><creator>June, Armond</creator><creator>Adade, Emmanuel E.</creator><creator>Li, Lu</creator><creator>Abusleme, Loreto</creator><creator>Dutzan, Nicolas</creator><creator>Yuan, Yao</creator><creator>Brenchley, Laurie</creator><creator>Bouladoux, Nicolas</creator><creator>Sakamachi, Yosuke</creator><creator>Palmer, Robert J.</creator><creator>Iglesias-Bartolome, Ramiro</creator><creator>Trinchieri, Giorgio</creator><creator>Garantziotis, Stavros</creator><creator>Belkaid, Yasmine</creator><creator>Valm, Alex M.</creator><creator>Diaz, Patricia I.</creator><creator>Holland, Steven M.</creator><creator>Moutsopoulos, Niki M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240409</creationdate><title>Epithelial-derived interleukin-23 promotes oral mucosal immunopathology</title><author>Kim, Tae Sung ; Ikeuchi, Tomoko ; Theofilou, Vasileios Ionas ; Williams, Drake Winslow ; Greenwell-Wild, Teresa ; June, Armond ; Adade, Emmanuel E. ; Li, Lu ; Abusleme, Loreto ; Dutzan, Nicolas ; Yuan, Yao ; Brenchley, Laurie ; Bouladoux, Nicolas ; Sakamachi, Yosuke ; Palmer, Robert J. ; Iglesias-Bartolome, Ramiro ; Trinchieri, Giorgio ; Garantziotis, Stavros ; Belkaid, Yasmine ; Valm, Alex M. ; Diaz, Patricia I. ; Holland, Steven M. ; Moutsopoulos, Niki M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-be231b96e09dc6cfc92cbac21907d9114c8e9f6ee5b4bdf15be40f5d389f07883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>barrier immunity</topic><topic>epithelial</topic><topic>Epithelial Cells</topic><topic>epithelial-intrinsic</topic><topic>flagellin</topic><topic>Humans</topic><topic>IL-23</topic><topic>Inflammation</topic><topic>Interleukin-23</topic><topic>oral mucosa</topic><topic>pathogenic Th17</topic><topic>Periodontitis</topic><topic>Pseudomonas aeruginosa</topic><topic>TLR5</topic><topic>Toll-Like Receptor 5 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Tae Sung</creatorcontrib><creatorcontrib>Ikeuchi, Tomoko</creatorcontrib><creatorcontrib>Theofilou, Vasileios Ionas</creatorcontrib><creatorcontrib>Williams, Drake Winslow</creatorcontrib><creatorcontrib>Greenwell-Wild, Teresa</creatorcontrib><creatorcontrib>June, Armond</creatorcontrib><creatorcontrib>Adade, Emmanuel E.</creatorcontrib><creatorcontrib>Li, Lu</creatorcontrib><creatorcontrib>Abusleme, Loreto</creatorcontrib><creatorcontrib>Dutzan, Nicolas</creatorcontrib><creatorcontrib>Yuan, Yao</creatorcontrib><creatorcontrib>Brenchley, Laurie</creatorcontrib><creatorcontrib>Bouladoux, Nicolas</creatorcontrib><creatorcontrib>Sakamachi, Yosuke</creatorcontrib><creatorcontrib>Palmer, Robert J.</creatorcontrib><creatorcontrib>Iglesias-Bartolome, Ramiro</creatorcontrib><creatorcontrib>Trinchieri, Giorgio</creatorcontrib><creatorcontrib>Garantziotis, Stavros</creatorcontrib><creatorcontrib>Belkaid, Yasmine</creatorcontrib><creatorcontrib>Valm, Alex M.</creatorcontrib><creatorcontrib>Diaz, Patricia I.</creatorcontrib><creatorcontrib>Holland, Steven M.</creatorcontrib><creatorcontrib>Moutsopoulos, Niki M.</creatorcontrib><creatorcontrib>NIDCD/NIDCR Genomics and Computational Biology Core</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Tae Sung</au><au>Ikeuchi, Tomoko</au><au>Theofilou, Vasileios Ionas</au><au>Williams, Drake Winslow</au><au>Greenwell-Wild, Teresa</au><au>June, Armond</au><au>Adade, Emmanuel E.</au><au>Li, Lu</au><au>Abusleme, Loreto</au><au>Dutzan, Nicolas</au><au>Yuan, Yao</au><au>Brenchley, Laurie</au><au>Bouladoux, Nicolas</au><au>Sakamachi, Yosuke</au><au>Palmer, Robert J.</au><au>Iglesias-Bartolome, Ramiro</au><au>Trinchieri, Giorgio</au><au>Garantziotis, Stavros</au><au>Belkaid, Yasmine</au><au>Valm, Alex M.</au><au>Diaz, Patricia I.</au><au>Holland, Steven M.</au><au>Moutsopoulos, Niki M.</au><aucorp>NIDCD/NIDCR Genomics and Computational Biology Core</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epithelial-derived interleukin-23 promotes oral mucosal immunopathology</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><addtitle>Immunity</addtitle><date>2024-04-09</date><risdate>2024</risdate><volume>57</volume><issue>4</issue><spage>859</spage><epage>875.e11</epage><pages>859-875.e11</pages><issn>1074-7613</issn><issn>1097-4180</issn><eissn>1097-4180</eissn><abstract>At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the prevalent oral disease periodontitis. Epithelial IL-23 expression localized to areas proximal to the disease-associated microbiome and was evident in experimental models and patients with common and genetic forms of disease. Mechanistically, flagellated microbial species of the periodontitis microbiome triggered epithelial IL-23 induction in a TLR5 receptor-dependent manner. Therefore, unlike other Th17-driven diseases, non-hematopoietic-cell-derived IL-23 served as an initiator of pathogenic inflammation in periodontitis. Beyond periodontitis, analysis of publicly available datasets revealed the expression of epithelial IL-23 in settings of infection, malignancy, and autoimmunity, suggesting a broader role for epithelial-intrinsic IL-23 in human disease. Collectively, this work highlights an important role for the barrier epithelium in the induction of IL-23-mediated inflammation.
[Display omitted]
•Epithelial IL-23 is evident in patients with common and Mendelian forms of periodontitis•Non-hematopoietic-cell-derived IL-23 is a pathogenic driver in experimental periodontitis•Flagellated microbes induce epithelial IL-23 through canonical TLR5 signaling•Epithelial IL-23 is evident across human barrier tissues and increased in Th17 diseases
Epithelial cells at mucosal surfaces provide a structural barrier and an immune defense system, but dysregulated epithelial responses can contribute to disease. Kim et al. reveal that epithelial-derived IL-23 is a pathogenic trigger in the oral mucosal disease periodontitis. Moreover, their findings suggest a broader role for epithelial-derived IL-23 in human Th17-mediated inflammatory diseases across barrier tissues.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38513665</pmid><doi>10.1016/j.immuni.2024.02.020</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1074-7613 |
ispartof | Immunity (Cambridge, Mass.), 2024-04, Vol.57 (4), p.859-875.e11 |
issn | 1074-7613 1097-4180 1097-4180 |
language | eng |
recordid | cdi_proquest_miscellaneous_2974003417 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | barrier immunity epithelial Epithelial Cells epithelial-intrinsic flagellin Humans IL-23 Inflammation Interleukin-23 oral mucosa pathogenic Th17 Periodontitis Pseudomonas aeruginosa TLR5 Toll-Like Receptor 5 - metabolism |
title | Epithelial-derived interleukin-23 promotes oral mucosal immunopathology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T07%3A31%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epithelial-derived%20interleukin-23%20promotes%20oral%20mucosal%20immunopathology&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Kim,%20Tae%20Sung&rft.aucorp=NIDCD/NIDCR%20Genomics%20and%20Computational%20Biology%20Core&rft.date=2024-04-09&rft.volume=57&rft.issue=4&rft.spage=859&rft.epage=875.e11&rft.pages=859-875.e11&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2024.02.020&rft_dat=%3Cproquest_cross%3E2974003417%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2974003417&rft_id=info:pmid/38513665&rft_els_id=S1074761324000967&rfr_iscdi=true |